DAFNA Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$395K Sell
2017
Q3
$480K Hold
2017
Q2
$436K Sell
2017
Q1
$767K Buy
2016
Q3
Sell
2016
Q2
$165K Buy
2015
Q4
Sell
2015
Q3
$99K Hold
2015
Q2
$135K Buy
2014
Q4
Sell
2014
Q3
$413K Buy